Achmea Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,009,890
| Closed | -$45.5M | – | 144 |
|
|
2025
Q3 | $45.5M | Buy |
1,009,890
+140,840
| +16% | +$6.58M | 0.57% | 36 |
|
|
2025
Q2 | $40.2M | Buy |
869,050
+203,103
| +30% | +$9.97M | 0.52% | 42 |
|
|
2025
Q1 | $40.6M | Buy |
665,947
+428,888
| +181% | +$25M | 0.59% | 36 |
|
|
2024
Q4 | $13.4M | Buy |
237,059
+25,429
| +12% | +$1.42M | 0.22% | 116 |
|
|
2024
Q3 | $10.9M | Sell |
211,630
-95,183
| -31% | -$4.47M | 0.18% | 147 |
|
|
2024
Q2 | $12.7M | Buy |
306,813
+29,110
| +10% | +$1.3M | 0.23% | 111 |
|
|
2024
Q1 | $15.1M | Buy |
277,703
+7,383
| +3% | +$376K | 0.29% | 93 |
|
|
2023
Q4 | $13.9M | Sell |
270,320
-130,743
| -33% | -$6.86M | 0.29% | 86 |
|
|
2023
Q3 | $23.3M | Sell |
401,063
-44,120
| -10% | -$2.7M | 0.51% | 38 |
|
|
2023
Q2 | $28.5M | Buy |
445,183
+38,793
| +10% | +$2.6M | 0.6% | 30 |
|
|
2023
Q1 | $28.2M | Buy |
406,390
+61,211
| +18% | +$4.32M | 0.82% | 21 |
|
|
2022
Q4 | $23.3M | Buy |
345,179
+14,098
| +4% | +$1.06M | 0.78% | 22 |
|
|
2022
Q3 | $23.5M | Sell |
331,081
-10,036
| -3% | -$728K | 0.83% | 21 |
|
|
2022
Q2 | $26.3M | Buy |
341,117
+147,744
| +76% | +$11.3M | 0.85% | 21 |
|
|
2022
Q1 | $14.1M | Buy |
193,373
+104,575
| +118% | +$7.02M | 0.37% | 56 |
|
|
2021
Q4 | $5.54M | Sell |
88,798
-29,328
| -25% | -$1.72M | 0.26% | 83 |
|
|
2021
Q3 | $6.99M | Buy |
118,126
+3,703
| +3% | +$244K | 0.21% | 134 |
|
|
2021
Q2 | $7.64M | Sell |
114,423
-46,695
| -29% | -$3.04M | 0.26% | 107 |
|
|
2021
Q1 | $10.2M | Sell |
161,118
-101,242
| -39% | -$6.3M | 0.35% | 64 |
|
|
2020
Q4 | $16.3M | Sell |
262,360
-32,913
| -11% | -$2.02M | 0.59% | 31 |
|
|
2020
Q3 | $17.8M | Buy |
+295,273
| New | +$17.8M | 0.74% | 21 |
|
|
2020
Q1 | – | Sell |
-236,459
| Closed | -$15.2M | – | 293 |
|
|
2019
Q4 | $15.2M | Buy |
236,459
+113,897
| +93% | +$6.52M | 0.59% | 34 |
|
|
2019
Q3 | $6.22M | Sell |
122,562
-13,464
| -10% | -$633K | 0.25% | 106 |
|
|
2019
Q2 | $6.17M | Buy |
136,026
+15,880
| +13% | +$740K | 0.24% | 105 |
|
|
2019
Q1 | $5.73M | Sell |
120,146
-41,662
| -26% | -$2.08M | 0.24% | 107 |
|
|
2018
Q4 | $8.41M | Buy |
161,808
+19,684
| +14% | +$1.06M | 0.39% | 60 |
|
|
2018
Q3 | $8.82M | Sell |
142,124
-30,386
| -18% | -$1.8M | 0.33% | 70 |
|
|
2018
Q2 | $9.54M | Buy |
172,510
+9,411
| +6% | +$508K | 0.33% | 75 |
|
|
2018
Q1 | $10.3M | Buy |
163,099
+78,957
| +94% | +$5.08M | 0.35% | 71 |
|
|
2017
Q4 | $5.16M | Buy |
84,142
+29,732
| +55% | +$1.86M | 0.17% | 142 |
|
|
2017
Q3 | $3.46M | Buy |
54,410
+20,229
| +59% | +$1.18M | 0.2% | 132 |
|
|
2017
Q2 | $1.9M | Sell |
34,181
-82,479
| -71% | -$4.49M | 0.11% | 231 |
|
|
2017
Q1 | $6.34M | Buy |
+116,660
| New | +$6.4M | 0.3% | 83 |
|
Other funds holding BMY
Achmea Investment Management's BMY Position: Q4 2025 in Review
Achmea Investment Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 1,009,890 shares — an estimated $45.5M sold.
Achmea Investment Management first reported a position in BMY in Q1 2017 and held it in 33 quarters. The position peaked at $45.5M in Q3 2025. 2,455 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Achmea Investment Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Achmea Investment Management sold 1,009,890 Bristol-Myers Squibb shares in Q4 2025, an estimated $45.5M.
- Achmea Investment Management first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 33 quarters.
- Achmea Investment Management's Bristol-Myers Squibb position peaked at $45.5M in Q3 2025.
- 2,455 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Achmea Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.